Ask AI
ProCE Banner Activity

Assessing Risk Factors for PBC Progression, Defining Adequate Biochemical Response

Slideset

Which people with PBC are at highest risk for disease progression, and how should this inform your plans for when to assess whether to move on to second-line therapy? Learn about the evidence-based biochemical targets for people with PBC who are receiving first-line therapy.

Released: January 06, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This activity is intended for physicians, including hepatologists and gastroenterologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals involved in the care of patients with PBC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify people with PBC who are at highest risk for disease progression

  • Develop monitoring plans, including evidence-based biochemical targets, for people with PBC who are on first-line therapy